Annarita Chieti

Annarita Chieti

Auto-generated profile, based on publicly available information

Annarita Chieti

Personalized Medicine Laboratory, National Institute of Gastroenterology “S. De Bellis”, Via Turi 27, Castellana Grotte, 70013 Bari, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2018 in Seminars in Liver Disease
Verified
Journal Article
Closed access
PDF file
SMSerena Mancarella
Serena Mancarella
ACAntonio Cigliano
Antonio Cigliano
ACAnnarita Chieti
Annarita Chieti
GGGianluigi Giannelli
Gianluigi Giannelli
FDFrancesco Dituri
Francesco Dituri
Therapeutic attempts to treat hepatocellular carcinoma (HCC) frequently result in a poor response or treatment failure. The efficacy of approved drugs and survival expectancies is affected by an ample degree of variability that can be explained at least in part by the enormous between-patient cellular and molecular heterogeneity of this neoplasm. Transforming growth factor-β (TGF-β) is hyperactivated in a large fraction of HCCs, where it influences complex interactive networks covering multiple cell types and a plethora of other local soluble ligands, ultimately establishing several malignancy traits. This cytokine boosts the invasiveness of cancerous epithelial cells through promoting the epithelial-to-mesenchymal transition program, but also skews the phenotype of immune cells toward a tumor-supporting status. Here, we discuss recent strategies pursued to offset TGF-β-dependent processes that promote metastatic progression and immune surveillance escape in solid cancers, including HCC. Moreover, we report findings indicating that TGF-β reduces the expression of the proinflammatory factors CCL4 and interleukin-1β (IL-1β in human ex vivo treated HCC tissues. While this is consistent with the anti-inflammatory properties of TGF-β, whether it is an outright tumor promoter or suppressor is still a matter of some debate. Indeed, IL-1β has also been shown to support angiogenesis and cell invasiveness in some cancers. In addition, we describe an inhibitory effect of TGF-β on the secretion of CCL2 and CXCL1 by HCC-derived fibroblasts, which suggests the existence of an indirect stroma-mediated functional link between TGF-β and downstream immunity.

1 September 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SSS. Simone
S. Simone
FRFederica Rascio
Federica Rascio
GCGiuseppe Castellano
Giuseppe Castellano
CDC. Divella
C. Divella
ACA. Chieti
A. Chieti
GGG. Grandaliano
G. Grandaliano

25 July 2019 in Cells
Verified
Journal Article
Open access
PDF file
Maria ScavoMaria Scavo
Maria Scavo
NDNicoletta Depalo
Nicoletta Depalo
FRFederica Rizzi
Federica Rizzi
chiara.ingrosso Ingrossochiara.ingrosso Ingrosso
chiara.ingrosso Ingrosso
Elisabetta FanizzaElisabetta Fanizza
Elisabetta Fanizza
Gianluigi  GiannelliGianluigi Giannelli
Gianluigi Giannelli
Extracellular vesicles (EVs) are involved in intercellular communication during carcinogenesis, and cancer cells are able to secrete EVs, in particular exosomes containing molecules, that can be transferred to recipient cells to induce pathological processes and significant modifications, as metastasis, increase of proliferation, and carcinogenesis evolution. FZD proteins, a family of receptors comprised in the Wnt signaling pathway, play an important role in carcinogenesis of the gastroenteric tract. Here, a still unknown role of Frizzled 10 (FZD10) protein was identified. In particular, the presence of FZD10 and FZD10-mRNA in exosomes extracted from culture medium of the untreated colorectal, gastric, hepatic, and cholangio cancer cell lines, was detected. A substantial reduction in the FZD10 and FZD10-mRNA level was achieved in FZD10-mRNA silenced cells and in their corresponding exosomes. Concomitantly, a significant decrease in viability of the silenced cells compared to their respective controls was observed. Notably, the incubation of silenced cells with the exosomes extracted from culture medium of the same untreated cells promoted the restoration of the cell viability and, also, of the FZD10 and FZD10-mRNA level, thus indicating that the FZD10 and FZD10-mRNA delivering exosomes may be potential messengers of cancer reactivation and play an active role in long-distance metastatization.